BONE BIOLOGICS CORPORATION APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
BONE BIOLOGICS CORPORATION (BBLG) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $8.25 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-14
- BONE BIOLOGICS CORPORATION apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was $8.25K, a 88.68% decline year-over-year.
- BONE BIOLOGICS CORPORATION apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $23.50K, a 53.55% decline year-over-year.
- BONE BIOLOGICS CORPORATION apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $87.18K, a 385.93% increase year-over-year.
- BONE BIOLOGICS CORPORATION apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-06-30 was $72.90K, a 317.93% increase year-over-year.
- BONE BIOLOGICS CORPORATION apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $256.36K, a 35.77% increase from fiscal 2024.
- BONE BIOLOGICS CORPORATION apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $188.82K, a 23.74% increase from fiscal 2023.
- BONE BIOLOGICS CORPORATION apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $152.60K, a 42.77% decline from fiscal 2022.
- BONE BIOLOGICS CORPORATION apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $266.63K, a 28.79% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.25K 10-Q · filed 2026-08-14 | $31.76K derived: sum of 2 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $23.50K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $256.36K 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $87.18K 10-Q · filed 2025-11-14 | $160.08K derived: sum of 2 quarters · filed 2026-08-14 | $210.68K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2025-06-30 | $72.90K 10-Q · filed 2026-08-14 | $123.50K derived: sum of 2 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $50.60K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $188.82K 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $17.94K 10-Q · filed 2025-11-14 | $35.38K derived: sum of 2 quarters · filed 2025-11-14 | $88.06K derived: sum of 3 quarters · filed 2025-11-14 | |
| 2024-06-30 | $17.44K 10-Q · filed 2025-11-14 | $70.12K derived: sum of 2 quarters · filed 2025-11-14 | ||
| 2024-03-31 | $52.68K 10-Q · filed 2025-11-14 | |||
| 2023-12-31 | $152.60K 10-K · filed 2025-02-26 | |||
| 2023-09-30 | $20.03K 10-Q · filed 2024-11-14 | $36.70K derived: sum of 2 quarters · filed 2024-11-14 | $81.46K derived: sum of 3 quarters · filed 2024-11-14 | |
| 2023-06-30 | $16.67K 10-Q · filed 2024-11-14 | $61.43K derived: sum of 2 quarters · filed 2024-11-14 | ||
| 2023-03-31 | $44.76K 10-Q · filed 2024-11-14 | |||
| 2022-12-31 | $266.63K 10-K · filed 2024-02-21 | |||
| 2022-09-30 | $32.53K 10-Q · filed 2023-11-14 | $51.28K derived: sum of 2 quarters · filed 2023-11-14 | $204.13K derived: sum of 3 quarters · filed 2023-11-14 | |
| 2022-06-30 | $18.75K 10-Q · filed 2023-11-14 | $171.59K derived: sum of 2 quarters · filed 2023-11-14 | ||
| 2022-03-31 | $152.84K 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $207.03K 10-K · filed 2023-03-30 | |||
| 2019-12-31 | $49.69K 10-K · filed 2021-04-15 | |||
| 2019-09-30 | $7.29K 10-Q · filed 2021-04-15 | $20.84K derived: sum of 2 quarters · filed 2021-04-15 | $46.57K derived: sum of 3 quarters · filed 2021-04-15 | |
| 2019-06-30 | $13.55K 10-Q · filed 2021-04-15 | $39.27K derived: sum of 2 quarters · filed 2021-04-15 | ||
| 2019-03-31 | $25.72K 10-Q · filed 2021-04-15 | |||
| 2018-12-31 | $516.64K 10-K · filed 2020-03-30 | |||
| 2018-09-30 | $101.16K 10-Q · filed 2019-11-14 | $296.96K derived: sum of 2 quarters · filed 2019-11-14 | $492.75K derived: sum of 3 quarters · filed 2019-11-14 | |
| 2018-06-30 | $195.79K 10-Q · filed 2019-11-14 | $391.59K derived: sum of 2 quarters · filed 2019-11-14 | ||
| 2018-03-31 | $195.79K 10-Q · filed 2019-11-14 | |||
| 2017-12-31 | $1.62M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |